Skip to main content
Premium Trial:

Request an Annual Quote

SeqWright to Take Stake in LaserGen

NEW YORK (GenomeWeb News) – SeqWright is set to make an undisclosed equity investment in LaserGen, a Houston-based developer of chemistries for next-generation sequencing applications.

LaserGen said that SeqWright's decision to invest was prompted by LaserGen's plans to commercialize its reversible terminator chemistry, called Lightning Terminators, for next-generation sequencing applications. The firm said that its technology can increase the speed, throughput, and read length of next-generation sequencing, while lowering cost, by attaching a special terminating group directly to the base, which frees up the 3'-hydroxyl group.

LaserGen said that it would bring the Lightning Terminators chemistry to market as reagent kits as early as next year, and that it expects to form strategic partnerships with existing next-generation instrument manufacturers. It believes SeqWright can help it achieve that goal.

Further terms of the investment or collaboration with SeqWright were not disclosed.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.